05.12.2017 Views

Home Infusion Therapy Market growing at 9.0% from 2017 to 2024

Get more details @ http://bit.ly/2djHSwn Companies operating in home infusion therapy includes Baxter, CareFusion, Smiths Medical, Fresenius Kabi, Caesarea Medical Electronics, B. Braun Melsungen, ICU Medical, Terumo and JMS.

Get more details @ http://bit.ly/2djHSwn
Companies operating in home infusion therapy includes Baxter, CareFusion, Smiths Medical, Fresenius Kabi, Caesarea Medical Electronics, B. Braun Melsungen, ICU Medical, Terumo and JMS.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Home</strong> <strong>Infusion</strong> <strong>Therapy</strong> <strong>Market</strong> share forecast <strong>to</strong><br />

reach $28bn by <strong>2024</strong>: Global <strong>Market</strong> Insights Inc.<br />

Over the recent years, home infusion therapy market has witnessed an expeditious<br />

growth trend, courtesy – the exemplary advancements in medical technology space.<br />

The rise of innov<strong>at</strong>ive technological solutions has been facilit<strong>at</strong>ed seamlessly by a<br />

robust regul<strong>at</strong>ory framework, which has further positively impacted the competitive<br />

prospects among the prominent industry players. Furthermore, the technological<br />

progress being observed in infusion pumps, which are increasingly being utilized in<br />

medical setups such as hospitals, nursing homes, and homecare, shall propel the<br />

home infusion therapy industry in the upcoming years.<br />

To cite the most recent development in this industry, one of the prominent medical<br />

device manufacturers, Smiths Medical, has recently unveiled an upgraded version of<br />

ambul<strong>at</strong>ory infusion pump, which has now been equipped with wireless<br />

communic<strong>at</strong>ion linked <strong>to</strong> PharmGuard Server software th<strong>at</strong> allows clinicians <strong>to</strong><br />

securely employ software upd<strong>at</strong>es, track the pump loc<strong>at</strong>ions, manage the<br />

performance of pumps remotely and download d<strong>at</strong>a reports. Such dynamic and<br />

smart product innov<strong>at</strong>ions with high-degree of accuracy and precision are set <strong>to</strong><br />

assist the swift expansion of home infusion therapy market. As per a report<br />

published by Global <strong>Market</strong> Insights Inc., home infusion therapy market size<br />

witnessed a valu<strong>at</strong>ion of over $14 Billion in 2016.<br />

<strong>Home</strong> infusion therapy, in the recent past, has gained renowned traction across the<br />

globe, as it has continuously been contempl<strong>at</strong>ed as the most appropri<strong>at</strong>e altern<strong>at</strong>ive<br />

for people suffering <strong>from</strong> chronic diseases. Concurrently, the significant rise in the<br />

geri<strong>at</strong>ric popul<strong>at</strong>ion around the globe, who are vulnerable <strong>to</strong> chronic diseases such<br />

as cancer, diabetes, cardiovascular ailments, and respir<strong>at</strong>ory disorders have<br />

contributed <strong>to</strong> the growth of home infusion therapy market in an unprecedented way.<br />

Speaking of the applic<strong>at</strong>ion landscape of home infusion therapy industry, the<br />

predominant ones include hydr<strong>at</strong>ion therapy, chemotherapy, anti-infectives, enteral<br />

nutrition, specialty pharmaceuticals, among others. Out of these, anti-infectives<br />

contributed <strong>to</strong> a sizeable revenue share in 2016. The investment in anti-infectives<br />

has been stagnant in the last few years, as no new anti-infective has been formed for<br />

community-acquired bacterial pneumonia (CABP) in the last 15 years. This trend is<br />

set <strong>to</strong> change in the near future, as a leading Irish biopharma Nabriva Therapeutics<br />

plc has succeeded in the initial phases of evalu<strong>at</strong>ing a new anti-infective <strong>to</strong> tre<strong>at</strong><br />

CABP. Such encouraging initi<strong>at</strong>ives undertaken by industry players in anti-biotics<br />

and other applic<strong>at</strong>ions are bound <strong>to</strong> aid the home infusion therapy market expansion.<br />

1 | P a g e


U.S. <strong>Home</strong> <strong>Infusion</strong> <strong>Therapy</strong> <strong>Market</strong> size, By Product, 2013-<strong>2024</strong><br />

(USD Million)<br />

Browse key industry insights spread across 95 pages with 52 market d<strong>at</strong>a tables & 9<br />

figures & charts <strong>from</strong> the report <strong>Home</strong> <strong>Infusion</strong> <strong>Therapy</strong> <strong>Market</strong> in detail along with<br />

the table of contents:<br />

https://www.gminsights.com/industry-analysis/home-infusion-therapy-market-report<br />

Meanwhile, it would be well advised <strong>to</strong> take note of the anticip<strong>at</strong>ed challenges th<strong>at</strong><br />

might affect the home infusion therapy industry in the upcoming time period. The<br />

industry has been marred by the haphazard, inadequ<strong>at</strong>e and complex<br />

reimbursement system th<strong>at</strong> has neg<strong>at</strong>ively impacted business growth. Add <strong>to</strong> it, the<br />

inappropri<strong>at</strong>e use of infusion therapy devices and improper dose administr<strong>at</strong>ion<br />

might severely hamper the growth potential of home infusion therapy industry.<br />

Regionally, the U.S. home infusion therapy market is expected <strong>to</strong> gain commendable<br />

momentum over the forecast period, owing <strong>to</strong> the presence of prominent industry<br />

players complemented with increasing demand for homecare facilities, simplified<br />

access <strong>to</strong> healthcare, and suitable reimbursement policies. Speaking along similar<br />

lines, the UK home infusion therapy industry, especially Germany, stands <strong>to</strong> gain<br />

noteworthy benefits as the advancing infusion devices and their increased usage in<br />

pain management has been encouraging.<br />

The home infusion therapy market is spanned by highly aggressive companies such<br />

as Smiths Medical, Carefusion, Baxter, ICU Medical, JMS, Terumo, Caesarea<br />

Medical Electronics, Fresenius Kabi, B.Braun Melsungen, <strong>to</strong> name a few. The<br />

predominant industry players have coupled their product innov<strong>at</strong>ions and<br />

technological advancements with robust mergers and alliances <strong>to</strong> form a strong<br />

framework <strong>to</strong> accentu<strong>at</strong>e sustained growth and expand the cus<strong>to</strong>mer base. Citing an<br />

instance, the world’s preeminent pure-play infusion firm, ICU Medical Inc., has<br />

recently wrapped up its acquisition of Hospira <strong>Infusion</strong> Systems business <strong>from</strong> Pfizer<br />

2 | P a g e


Inc., a pharmaceutical behemoth. This alliance strengthens the resolve of ICU<br />

Medical Inc. <strong>to</strong> form a company with a complete intravenous therapy product range<br />

<strong>from</strong> non-dedic<strong>at</strong>ed infusion sets <strong>to</strong> smart infusion pumps.<br />

The home infusion therapy industry anticip<strong>at</strong>es further collabor<strong>at</strong>ions and<br />

acquisitions of leading players with upcoming firm, in turn, boosting the product and<br />

profitability portfolio of this domain. According <strong>to</strong> a report published by Global <strong>Market</strong><br />

Insights, Inc., home infusion therapy market is forecast <strong>to</strong> expand <strong>at</strong> over 9% CAGR<br />

<strong>from</strong> <strong>2017</strong>-<strong>2024</strong>.<br />

Table of Content of <strong>Home</strong> <strong>Infusion</strong> <strong>Therapy</strong> <strong>Market</strong>:<br />

Chapter 1. Methodology<br />

1.1. Methodology<br />

1.1.1. Initial d<strong>at</strong>a explor<strong>at</strong>ion<br />

1.1.2. St<strong>at</strong>istical model and forecast<br />

1.1.3. Industry insights and valid<strong>at</strong>ion<br />

1.1.4. <strong>Market</strong> definition and forecast parameters<br />

1.2. D<strong>at</strong>a sources<br />

1.2.1. Primary<br />

1.2.2. Secondary<br />

Chapter 2. Executive Summary<br />

2.1. <strong>Home</strong> infusion therapy industry 360 0 synopsis, 2013 - <strong>2024</strong> (USD Million)<br />

2.1.1. Business trends<br />

2.1.2. Product trends<br />

2.1.3. Applic<strong>at</strong>ion trends<br />

2.1.4. Regional trends<br />

Chapter 3. <strong>Home</strong> <strong>Infusion</strong> <strong>Therapy</strong> Industry Insights<br />

3.1. Industry segment<strong>at</strong>ion<br />

3 | P a g e


3.2. Industry landscape, 2013 - <strong>2024</strong> (USD Million)<br />

3.3. Industry impact forces<br />

3.3.1. Growth drivers<br />

3.3.1.1. Growing geri<strong>at</strong>ric popul<strong>at</strong>ion<br />

3.3.1.2. Advancement in technology<br />

3.3.1.3. Growing hospital acquired infections<br />

3.3.1.4. Presence of home healthcare facilities<br />

3.3.1.5. Rising prevalence of chronic diseases<br />

3.3.2. Industry pitfalls & challenges<br />

3.3.2.1. Dearth of reimbursement<br />

3.3.3. Growth potential analysis<br />

3.3.3.1. By product<br />

3.3.3.2. By applic<strong>at</strong>ion<br />

3.4. Regul<strong>at</strong>ory landscape<br />

3.4.1. U.S.<br />

3.4.2. Europe<br />

3.5. Porter's analysis<br />

3.6. Competitive landscape, 2016<br />

3.6.1. Str<strong>at</strong>egy Dashboard<br />

3.7. PESTEL analysis<br />

About Global <strong>Market</strong> Insights:<br />

Global <strong>Market</strong> Insights, Inc., headquartered in Delaware, U.S., is a global market<br />

research and consulting service provider; offering syndic<strong>at</strong>ed and cus<strong>to</strong>m research<br />

reports along with growth consulting services. Our business intelligence and industry<br />

4 | P a g e


esearch reports offer clients with penetr<strong>at</strong>ive insights and actionable market d<strong>at</strong>a<br />

specially designed and presented <strong>to</strong> aid str<strong>at</strong>egic decision making. These exhaustive<br />

reports are designed via a proprietary research methodology and are available for<br />

key industries such as chemicals, advanced m<strong>at</strong>erials, technology, renewable<br />

energy and biotechnology.<br />

Contact Us:<br />

Arun Hegde<br />

Corpor<strong>at</strong>e Sales, USA<br />

Global <strong>Market</strong> Insights, Inc.<br />

Phone: 1-302-846-7766<br />

Toll Free: 1-888-689-0688<br />

Email: sales@gminsights.com<br />

Website: https://www.gminsights.com/<br />

5 | P a g e

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!